Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707538 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
A Phase 1 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00707538 is a Phase 1 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 12 participants.
The verdict
NCT00707538, a Phase 1 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
Interventions
- DRUG BMS747158
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707538
The ClinicalTrials.gov registry entry for NCT00707538 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BMS747158 is the first listed.
NCT00707538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707538 about?
NCT00707538 is a clinical study titled "A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress". The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
What is the current status of trial NCT00707538?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00707538?
The interventions under investigation include: BMS747158 (DRUG).
Who is sponsoring clinical trial NCT00707538?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.